Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

Pertussis Infection in Adolescents and Adults With Prolonged Cough

NCT01597687 ·Status: COMPLETED ·Phase: NA

Optimising the Timing of Whooping Cough Immunisation in MUMs

NCT03908164 ·Status: UNKNOWN ·Phase: PHASE4

Pertussis (Tdap) Vaccination in Pregnancy

NCT01698346 ·Status: COMPLETED ·Phase: PHASE4

Pediatric Pertussis in Ambulatory Settings

NCT04807712 ·Status: RECRUITING

The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine

NCT00197782 ·Status: COMPLETED ·Phase: PHASE4

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

NCT01129362 ·Status: COMPLETED

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines

NCT05193734 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

NCT01449812 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants

NCT00628303 ·Status: WITHDRAWN ·Phase: PHASE3

Pertussis Vaccination in Pregnant Women

NCT03909126 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

NCT06605755 ·Status: RECRUITING ·Phase: NA

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

NCT00092469 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study of Intramuscular TAK-816 in Healthy Infants

NCT02074345 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

NCT01003431 ·Status: WITHDRAWN ·Phase: PHASE3

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

NCT03973905 ·Status: COMPLETED

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

NCT01110044 ·Status: WITHDRAWN ·Phase: PHASE2

Gambia Pertussis Study (GaPs)

NCT03606096 ·Status: UNKNOWN ·Phase: PHASE4

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

NCT01986322 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

NCT01402713 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:

NCT04916847 ·Status: COMPLETED

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

NCT04424316 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immune Response of Different Pediatric Combination Vaccines.

NCT00255047 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

NCT05952596 ·Status: UNKNOWN ·Phase: PHASE1

Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China

NCT01044316 ·Status: COMPLETED ·Phase: PHASE3